OTC:DFPH | EBITDA | Starling Oncology, Inc.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$4.9M
2025-12-31-$5.28M
2025-03-31-$8.13M
2024-12-31-$10.22M
2024-03-31-$16.48M
2023-12-31-$13.71M
2023-03-31-$31.6M
2022-12-31-$23.89M
2022-03-31-$17.48M
2021-12-31-$39.91M
2021-03-31-$976,000.00

Annual EBITDA

DateEBITDA
2025-12-31-$29.14M
2024-12-31-$53.83M
2023-12-31-$71.15M
2022-12-31-$77.54M
2021-12-31-$42.52M
2020-12-31-$5.02M